beta

ABIO

ARCA biopharma, Inc.

Abio

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.

Market Cap: 8.51 Million

Primary Exchange: NASDAQ

Website: http://www.arcabiopharma.com

Shares Outstanding: 1.59 Million

Float: 1.58 Million

Dividend: (%)

Beta: 0.0906777190077538

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Animal testing

Longest drawdown: 1881 trading days

From: 2013-01-31 To: 2019-12-10

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2015-09-04 7.0 1.0 7.0
2013-03-05 6.0 1.0 6.0
Data provided by IEX Cloud